Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 64,045 | 36,554 | 53,211 | 53,949 | 75,152 |
| Cost of Goods | 6,092 | 3,779 | 6,732 | 4,654 | 10,547 |
| Gross Profit | 57,953 | 32,775 | 46,479 | 49,295 | 64,605 |
| Operating Expenses | 37,004 | 28,602 | 46,967 | 33,612 | 51,340 |
| Operating Income | 21,041 | 4,952 | 244 | 16,337 | 13,812 |
| Interest Expense | 166 | 178 | 166 | 254 | 282 |
| Other Income | 694 | 387 | 648 | 645 | 557 |
| Pre-tax Income | 21,569 | 5,161 | 726 | 16,728 | 14,087 |
| Income Tax | 4,470 | 1,563 | 433 | 3,479 | 3,706 |
| Net Income Continuous | 17,099 | 3,598 | 293 | 13,249 | 10,381 |
| Minority Interests | 4,948 | 1,809 | 1,458 | 4,387 | 4,656 |
| Net Income | $12,151 | $1,789 | $-1,165 | $8,862 | $5,725 |
| EPS Basic Total Ops | 0.11 | 0.01 | -0.03 | 0.12 | 0.10 |
| EPS Basic Continuous Ops | 0.17 | 0.04 | -0.02 | 0.19 | 0.17 |
| EPS Diluted Total Ops | 0.11 | 0.01 | -0.02 | 0.12 | 0.10 |
| EPS Diluted Continuous Ops | 0.15 | 0.04 | -0.02 | 0.19 | 0.17 |
| EBITDA(a) | $22,216 | $5,996 | $1,360 | $17,619 | $15,049 |